2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Cyclophosphamide: new trials by email Literature Review of Cyclophosphamide trials Research Report on Cyclophosphamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) Chidamide combined with R-GDP - Chidamide, Lymphoma, B-Cell | Phase 2 | Unknown | Fudan University | 63 | 2017-12-21 | 2017-12-14 |
| Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma G-CSF, Bortezomib, Cyclophosphamide - Myeloma, Bortezomib | Phase 2 | Unknown | Second Affiliated Hospital of Soochow University | 60 | 2013-12-01 | 2014-01-06 |
Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms, Plasma Cell (1)
Neoplasms by Histologic Type (2) · Hemic and Lymphatic Diseases (1) · Lymphoma (1) · Neoplasms (1)
Bortezomib (1) · Cyclophosphamide (1) · Dexamethasone (1) · Granulocyte Colony-Stimulating Factor (1)
Fudan University (1) · Second Affiliated Hospital of Soochow University (1)
China (2)